Skip to main content
OpenTrials

Clinical trial condition

Uterine Diseases

Explore clinical trials studying Uterine Diseases. Study availability and eligibility vary by location and protocol.

3,046 public trials 692 recruiting studies
Refine in advanced search Browse all conditions

Uterine Diseases trial results

Completed

Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects

NCT00578227

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • GSK Investigational Site Surrey, British Columbia, Canada
  • GSK Investigational Site Brampton, Ontario, Canada
  • GSK Investigational Site Greater Sudbury, Ontario, Canada
  • GSK Investigational Site Newmarket, Ontario, Canada
View all 21 locations
View Trial Details
Completed

Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects

NCT00652938

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • GSK Investigational Site Nijmegen, Netherlands
  • GSK Investigational Site Rotterdam, Netherlands
  • GSK Investigational Site Linköping, Sweden
  • GSK Investigational Site Luleå, Sweden
View Trial Details
Completed

Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs

NCT00541970

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • GSK Investigational Site Edmonton, Alberta, Canada
  • GSK Investigational Site Langley, British Columbia, Canada
  • GSK Investigational Site St. John's, Newfoundland and Labrador, Canada
  • GSK Investigational Site Truro, Nova Scotia, Canada
View all 25 locations
View Trial Details
Completed

Fourth Dose of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + EP in Adult Females Previously Vaccinated With Three Doses of VGX-3100

NCT01188850

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +11 more
Locations
  • Lyndhurst Gynecologic Associates Winston-Salem, North Carolina, United States
  • Laurel Highlands, OB/GYN, P.C. Hopwood, Pennsylvania, United States
  • Clinical Research Puerto Rico San Juan, Puerto Rico
View Trial Details
Completed

Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer

NCT01767155

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • USC Norris Hospital and LAC+USC Medical Center Los Angeles, California, United States
  • University of California, Irvine - Medical Center Orange, California, United States
  • University of Colorado Aurora, Colorado, United States
View all 123 locations
View Trial Details

Related conditions